Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level

被引:37
作者
Cotreau, MM
von Moltke, LL
Beinfeld, MC
Greenblatt, DJ
机构
[1] Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA
[2] Tufts Univ, New England Med Ctr Hosp, Div Clin Pharmacol, Boston, MA 02111 USA
关键词
intestinal cytochrome P450 3A; RT-PCR; quantitative Western Blotting; midazolam hydroxylation; rat;
D O I
10.1016/S1056-8719(00)00086-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Studies were conducted to characterize assays for the isolation and quantitation of rat cytochrome P450 (CYP) 3A isoforms from hepatic and intestinal tissues. Isolated intestinal microsomes were analyzed for their alkaline phosphatase activity and CYP 3A immunoreactivity. The involvement of CYP 3A in the in vitro hydroxylation of midazolam (MDZ) was also evaluated using isoform specific chemical and antibody inhibitors. The effect of glycerol (a common constituent of the microsomal reconstitution buffer) concentration on in vitro MDZ hydroxylation was also investigated. Additionally, to verify that the intestinal preparation was adequate for use in studies investigating the induction of CYP 3A at the mRNA, protein, and catalytic activity within a single animal, a separate induction study was carried out with the CYP 3A inducer dexamethasone (DEX). A reverse transcription-polymerase chain reaction (RT-PCR) assay and a quantitative Western blotting method were used to reliably detect differences in CYP 3A mRNA and immunoreactivity between DEX- and vehicle (VH)-treated tissues. The in vitro hydroxylation of MDZ evaluated CYP 3A catalytic activity and identified increases in CYP 3A activity caused by DEX in comparison to VH. Collectively, these described techniques provide an experimental model to study xenobiotic induction of rat hepatic and intestinal CYP 3A from the molecular to the catalytic level in individual rats without the need for pooling of tissue. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:41 / 54
页数:14
相关论文
共 60 条
[51]   Midazolam hydroxylation by human liver microsomes in vitro: Inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents [J].
vonMoltke, LL ;
Greenblatt, DJ ;
Schmider, J ;
Duan, SX ;
Wright, CE ;
Harmatz, JS ;
Shader, RI .
JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (09) :783-791
[52]   INHIBITION OF ALPRAZOLAM AND DESIPRAMINE HYDROXYLATION IN-VITRO BY PAROXETINE AND FLUVOXAMINE - COMPARISON WITH OTHER SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTIDEPRESSANTS [J].
VONMOLTKE, LL ;
GREENBLATT, DJ ;
COURT, MH ;
DUAN, SX ;
HARMATZ, JS ;
SHADER, RI .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (02) :125-131
[53]  
VONMOLTKE LL, 1994, J PHARMACOL EXP THER, V268, P1278
[54]   IDENTIFICATION OF GLUCOCORTICOID-INDUCIBLE CYTOCHROMES-P-450 IN THE INTESTINAL-MUCOSA OF RATS AND MAN [J].
WATKINS, PB ;
WRIGHTON, SA ;
SCHUETZ, EG ;
MOLOWA, DT ;
GUZELIAN, PS .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (04) :1029-1036
[55]  
WATKINS PB, 1992, GASTROENTEROL CLIN N, V21, P511
[56]  
WEISER MM, 1973, J BIOL CHEM, V248, P2536
[57]   INHIBITION OF HUMAN CYP3A CATALYZED 1'-HYDROXY MIDAZOLAM FORMATION BY KETOCONAZOLE, NIFEDIPINE, ERYTHROMYCIN, CIMETIDINE, AND NIZATIDINE [J].
WRIGHTON, SA ;
RING, BJ .
PHARMACEUTICAL RESEARCH, 1994, 11 (06) :921-924
[58]  
Zhang QY, 1997, DRUG METAB DISPOS, V25, P21
[59]  
Zhang QY, 1996, DRUG METAB DISPOS, V24, P322
[60]  
Zhang YC, 1998, J PHARMACOL EXP THER, V287, P246